| Original language | English |
|---|---|
| Pages (from-to) | 2805-2808 |
| Number of pages | 4 |
| Journal | Journal of Clinical Oncology |
| Volume | 30 |
| Issue number | 23 |
| DOIs | |
| State | Published - 2012 |
Multitargeted tyrosine kinase inhibitors in unselected patients with advanced non-small-cell lung cancer (NSCLC): Impressions from MONET (the motesanib NSCLC efficacy and tolerability study)
Daniel Morgensztern, Roy S. Herbst
Research output: Contribution to journal › Editorial
5
Scopus
citations